These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22013710)

  • 1. [Pharmacokinetic process: does the site of drug action? Excretion of drugs].
    Carrillo Norte JA
    Rev Enferm; 2011 Sep; 34(9):24-31. PubMed ID: 22013710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saturable pharmacokinetics in the renal excretion of drugs.
    van Ginneken CA; Russel FG
    Clin Pharmacokinet; 1989 Jan; 16(1):38-54. PubMed ID: 2650954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and dosage adjustment in patients with renal dysfunction.
    Verbeeck RK; Musuamba FT
    Eur J Clin Pharmacol; 2009 Aug; 65(8):757-73. PubMed ID: 19543887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principles and clinical application of assessing alterations in renal elimination pathways.
    Tett SE; Kirkpatrick CM; Gross AS; McLachlan AJ
    Clin Pharmacokinet; 2003; 42(14):1193-211. PubMed ID: 14606929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of digoxin.
    Iisalo E
    Clin Pharmacokinet; 1977; 2(1):1-16. PubMed ID: 322907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of human pharmacokinetics - renal metabolic and excretion clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Nov; 59(11):1463-71. PubMed ID: 17976256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excretion of the dipeptidyl peptidase-4 inhibitor linagliptin in rats is primarily by biliary excretion and P-gp-mediated efflux.
    Fuchs H; Runge F; Held HD
    Eur J Pharm Sci; 2012 Apr; 45(5):533-8. PubMed ID: 22198311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human variability in the renal elimination of foreign compounds and renal excretion-related uncertainty factors for risk assessment.
    Dorne JL; Walton K; Renwick AG
    Food Chem Toxicol; 2004 Feb; 42(2):275-98. PubMed ID: 14667473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors contributing to variability in drug pharmacokinetics. IV. Renal excretion.
    Regårdh CG
    J Clin Hosp Pharm; 1985 Dec; 10(4):337-49. PubMed ID: 3912409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and excretion of phenol red in the channel catfish.
    Plakas SM; Stehly GR; Khoo L
    Xenobiotica; 1992 May; 22(5):551-7. PubMed ID: 1413870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of the human kidney to the metabolic clearance of drugs.
    Vree TB; Hekster YA; Anderson PG
    Ann Pharmacother; 1992 Nov; 26(11):1421-8. PubMed ID: 1477449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure.
    Hoyer J; Schulte KL; Lenz T
    Clin Pharmacokinet; 1993 Mar; 24(3):230-54. PubMed ID: 8462229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
    Staatz CE; Tett SE
    Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation.
    Fagerholm U
    J Pharm Pharmacol; 2008 May; 60(5):535-42. PubMed ID: 18416932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary excretion of drugs in man.
    Rollins DE; Klaassen CD
    Clin Pharmacokinet; 1979; 4(5):368-79. PubMed ID: 389528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of renal handling of radiopharmaceuticals.
    Trejtnar F; Laznicek M
    Q J Nucl Med; 2002 Sep; 46(3):181-94. PubMed ID: 12134135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal clearance of graphene oxide: glomerular filtration or tubular secretion and selective kidney injury association with its lateral dimension.
    Chen W; Wang B; Liang S; Wang M; Zheng L; Xu S; Wang J; Fang H; Yang P; Feng W
    J Nanobiotechnology; 2023 Feb; 21(1):51. PubMed ID: 36765370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and renal handling of 99mTc-labeled peptides.
    Trejtnar F; Laznicek M; Laznickova A; Mather SJ
    J Nucl Med; 2000 Jan; 41(1):177-82. PubMed ID: 10647621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting when biliary excretion of parent drug is a major route of elimination in humans.
    Hosey CM; Broccatelli F; Benet LZ
    AAPS J; 2014 Sep; 16(5):1085-96. PubMed ID: 25004821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principles of drug administration in renal insufficiency.
    Lam YW; Banerji S; Hatfield C; Talbert RL
    Clin Pharmacokinet; 1997 Jan; 32(1):30-57. PubMed ID: 9012555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.